We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
45 hedge funds and large institutions have $143M invested in Larimar Therapeutics in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 8
2.82% more ownership
Funds ownership: 91.81% → 94.63% (+2.8%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
21% less funds holding
Funds holding: 57 → 45 (-12)
31% less capital invested
Capital invested by funds: $206M → $143M (-$63.3M)
40% less call options, than puts
Call options by funds: $6K | Put options by funds: $10K
60% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 20
Holders
45
Holders Change
-12
Holders Change %
-21.05%
% of All Funds
0.78%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
16
Reduced
8
Closed
20
Calls
$6K
Puts
$10K
Net Calls
-$4K
Net Calls Change
-$4K
Top Buyers
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$8.22M |
| 2 |
DM
Deerfield Management
New York
|
+$7.75M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$5.18M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.34M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.13M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$9.02M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$4.21M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
-$3.36M |
| 4 |
CCM
CAAS Capital Management
New York
|
-$3.2M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$2.8M |
